Saxifraga extracts for cosmetic or therapeutic use on the skin
AssigneeTauDerma SA
InventorsVincent Mutel, Xavier Simonnet, Bruno Schnyder
Life of this patent
Estimating the term…
Abstract
An extract obtained from Saxifraga sp., Astrantia major, or a combination thereof and a method of treating or relieving an inflammatory-skin related condition in a subject is provided. The method comprises administering or applying a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor alpha and Interleukine-1beta activity. The inflammation may be inflammation of the skin and the composition may be a skin preparation for external use.
Claims15
A method of treating or relieving an inflammatory-related skin condition comprising, administering a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor (TNF)-alpha activity.
A method of treating or relieving a skin condition comprising, administering a composition comprising an effective amount of an extract from Saxifraga sp., Astrantia major or a combination thereof, and a carrier, wherein the effective amount of the extract inhibits tumor necrosis factor (TNF)-alpha activity, the skin condition resulting from, a bite, a sting, a skin rash, itching of the skin, blistering of the skin, sunburn, sunspot, burning of the skin, UV exposure or radiation, aging of the skin, reducing redness of the skin, reducing a decrease in skin firmness, a skin allergy, age related spots, atopic skin, psoriasis, atopic dermatitis, hair loss, exposure of the skin to a chemical irritant, exposure of the skin to a pollutant, exposure of the skin to dirt, exposure of the skin to debris, and a combination thereof.
Dependencies are inferred from the claim text.